Polypharmacy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Person who taking more than 5 medications Person who agree to participate in the research
Exclusion criteria
Exclusion criteria: Cancer (palliative care) patients Psychiatric disorders Patients who have already reviewed the prescription Patients judged inappropriate by the facility manager
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of drugs prescribed | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of PIMs prescribed Patient proportion who was reduced one or more medication without problems Patient proportion who was reduced one or more PIM without problems Medication adherence ADL score Frequency of occurrence of drug adverse events Quality of Life score Drug cost | — |
Countries
Japan
Contacts
Osaka University of Pharmaceutical Sciences Department of Social and Administrative Pharmacy